NICE has recommended durvalumab for NHS use in England as part of perioperative treatment for adults with resectable gastric or gastro-oesophageal junction adenocarcinoma. Medscape News UK Source link : https://www.medscape.com/viewarticle/nice-backs-first-immunotherapy-resectable-gastric-cancer-2026a1000frm?src=rss...
Read more


















